Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Dove Medical Press full text link Dove Medical Press Free PMC article
Full text links

Actions

Review
.2008;3(1):1-8.
doi: 10.2147/cia.s1043.

Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence

Affiliations
Review

Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence

Maria Garefalakis et al. Clin Interv Aging.2008.

Abstract

Estrogen-containing hormone therapy (HT) is the most widely prescribed and well-established treatment for menopausal symptoms. High quality evidence confirms that estrogen effectively treats hot flushes, night sweats and vaginal dryness. Progestins are combined with estrogen to prevent endometrial hyperplasia and are sometimes used alone for hot flushes, but are less effective than estrogen for this purpose. Data are conflicting regarding the role of androgens for improving libido and well-being. The synthetic steroid tibolone is widely used in Europe and Australasia and effectively treats hot flushes and vaginal dryness. Tibolone may improve libido more effectively than estrogen containing HT in some women. We summarize the data from studies addressing the efficacy, benefits, and risks of androgens, progestins and tibolone in the treatment of menopausal symptoms.

PubMed Disclaimer

References

    1. Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review. Maturitas. 1998;30:295–305. - PubMed
    1. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative randomized controlled trial. JAMA. 2004;291:1701–12. - PubMed
    1. Andrews H, Christie B, Colledge N, et al. Consensus Statement. J R Coll Physicians Edinb. 2004;34(suppl 13):2–3.
    1. Antoine C, Liebens F, Carly B, et al. Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. Climacteric. 2007;10:23–6. - PubMed
    1. Antunes CMF, Stolley PD, Rosenstein MB. Endometrial cancer and estrogen use: report of a large case control study. N Engl J Med. 1979;300:9–13. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Full text links
Dove Medical Press full text link Dove Medical Press Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2026 Movatter.jp